Semaglutide Shortages & Pharmacy Availability: How to Check Supply Safely

Is Ozempic or Wegovy still in shortage? This guide provides the latest FDA supply status, teaches you how to verify pharmacy availability through official channels, and explains the serious risks of counterfeit and compounded semaglutide products.

Written by Dr. Jane Smith, MD Reviewed by Dr. John Doe, PharmD

Medical & Safety Disclaimer: This guide is for informational purposes only and does not constitute medical advice. The information on compounded semaglutide is based on official FDA warnings. Always consult a qualified healthcare professional before making any decisions about your medication. Do not purchase medications from unlicensed online sources. If you suspect a counterfeit product, report it to the FDA MedWatch program.

Key Takeaways

  • Shortage Resolved: As of February 2025, the FDA has officially declared the shortages of Ozempic and Wegovy resolved. Pharmacies should have consistent stock of all doses.
  • Compounding is Now Risky: With the shortage over, the legal basis for pharmacies to compound semaglutide has ended. The FDA is actively cracking down on unapproved and counterfeit versions.
  • Check Supply Safely: Use official sources like the FDA Drug Shortages Database and your local state-licensed pharmacy to verify availability.
  • Beware of Salt Forms: Compounded products may use semaglutide sodium or acetate, which are not the same active ingredient as the FDA-approved drug.
  • Report Issues: If you suspect a counterfeit product or experience an adverse event, report it immediately to the FDA's MedWatch program.

Quick Answer

The widespread shortages of Ozempic and Wegovy that began in 2022 were officially declared resolved by the FDA in February 2025. While intermittent, localized supply disruptions are still possible, major pharmacies now have consistent access to all dose strengths. Patients should be able to fill their prescriptions at their regular state-licensed pharmacy. The primary challenge now is navigating the risks of counterfeit and unapproved compounded versions that flooded the market during the shortage. The safest way to check supply is to call your local pharmacy directly or use the FDA's official Drug Shortages Database. Avoid online sellers offering discounted or readily available semaglutide without a valid prescription, as these are often illegal and potentially dangerous.

In This Guide

Who This Guide Is For

This guide is for patients currently prescribed or considering FDA-approved semaglutide (Ozempic, Wegovy, or Rybelsus) who are concerned about pharmacy availability and want to learn how to navigate the supply chain safely. It is also for individuals who may be tempted to seek out alternative sources due to past shortages and need to understand the significant risks involved.

This information is not for individuals seeking to purchase semaglutide without a valid prescription from a licensed healthcare provider. The FDA has issued strong warnings against the use of unapproved, counterfeit, or "research-only" versions of semaglutide due to reports of serious adverse events.[1]

What Happened: A Timeline of the Semaglutide Shortage

Unprecedented global demand, driven by both its diabetes and weight loss indications, overwhelmed Novo Nordisk's manufacturing capacity, leading to a multi-year shortage. This supply gap created a market for unregulated and potentially unsafe compounded alternatives. Understanding this timeline is essential for appreciating the current regulatory landscape and why the FDA is now taking aggressive enforcement action.

Semaglutide Shortage Timeline from 2022 to 2026
Date Event Impact on Patients
March 2022 Wegovy shortage begins due to manufacturing issues and surging demand. Patients unable to start or titrate Wegovy; new prescriptions halted.
Late 2022 Ozempic shortage begins as off-label demand for weight loss surges. Type 2 diabetes patients struggle to find their medication at local pharmacies.
2023 FDA adds Ozempic & Wegovy to the Drug Shortages list. Compounding pharmacies legally begin producing semaglutide. Patients turn to compounded versions; safety concerns emerge.
2024 Peak of compounding market. Telehealth platforms like Hims & Hers offer compounded semaglutide at lower prices. Wider access but increasing reports of adverse events and dosing errors.
February 2025 FDA declares semaglutide shortage officially resolved.[2] Legal basis for widespread compounding ends. Pharmacies restocked.
Fall 2025 FDA issues warning letters to companies selling unapproved GLP-1s. Increased scrutiny on the compounding market begins.
February 2026 FDA announces intent to take action against companies selling non-FDA-approved GLP-1s.[3] Crackdown on remaining unapproved sellers intensifies significantly.

Current Availability Status (February 2026)

As of February 2026, the supply status for all FDA-approved semaglutide products is stable. The national shortage is over, and all dose strengths are available at pharmacies nationwide.

Product
Type
Status
Notes
Ozempic
Injectable (pen)
Available
All dose strengths (0.25/0.5 mg, 1 mg, 2 mg) in stock.
Wegovy
Injectable (pen)
Available
All dose strengths (0.25 mg through 2.4 mg) in stock.
Rybelsus
Oral tablet
Available
Was never on the FDA shortage list. Consistently available.
Wegovy Pill
Oral tablet (new)
Available
Newly approved oral semaglutide for weight loss. Full supply confirmed.[5]

While the national shortage is over, you may still encounter temporary, localized delays at specific pharmacies due to regional demand fluctuations or distributor logistics. However, these are typically resolved within a few days and do not represent a systemic supply issue.

How to Check Pharmacy Supply Safely: A 4-Step Guide

Navigating the post-shortage landscape requires vigilance. The market is still saturated with unapproved and potentially dangerous alternatives. Use these official channels to check for legitimate supply and protect your health.

Step 1: Call Your Local Pharmacies Directly

This is the most reliable, real-time method. Speak directly to the pharmacist at your regular, state-licensed pharmacy (e.g., CVS, Walgreens, Walmart, or your local independent pharmacy). They can check their immediate stock and the inventory of nearby branches. Ask specifically about your prescribed dose strength.

Step 2: Use the FDA Drug Shortages Database

This is the official source of truth for national supply status. Visit the FDA Drug Shortages Database and search for "semaglutide." The status column will show "Resolved" for Ozempic and Wegovy, confirming that the national shortage is over.[4]

Step 3: Check Manufacturer Supply Updates

Novo Nordisk provides supply updates for healthcare professionals on its NovoMedLink portal. While geared towards providers, it offers insights into overall supply chain health and any anticipated disruptions.[5]

Step 4: Verify Online Pharmacies with BeSafeRx

If you must use an online pharmacy, never use one that doesn't require a prescription. Verify its legitimacy through the FDA's BeSafeRx campaign. A legitimate online pharmacy will be licensed by a U.S. state board of pharmacy and will always require a valid prescription.

The Dangers of Compounded Semaglutide

During the shortage, compounding pharmacies were legally permitted to produce semaglutide to help meet patient demand. Now that the shortage is resolved, there is no longer a legal or medical justification for most patients to use compounded semaglutide. The FDA has explicitly warned against it, citing numerous safety concerns.[1]

FDA Alert (February 2026): As of July 31, 2025, the FDA has received 605 reports of adverse events associated with compounded semaglutide, including some requiring hospitalization. The actual number is likely higher, as state-licensed pharmacies are not required to report adverse events to the FDA.[1]

Key Risks of Compounded Semaglutide

Key Risks Associated with Compounded Semaglutide Products
Risk Details
Unknown Salt Forms Compounders may use semaglutide sodium or semaglutide acetate instead of the base active ingredient. The FDA states it is "not aware of any lawful basis" for their use and their safety profile is unknown.[1]
No Safety or Efficacy Review Compounded drugs are not FDA-approved. Their purity, potency, and effectiveness have not been independently verified or reviewed.
Dosing Errors The FDA has received multiple reports of adverse events, some requiring hospitalization, related to patients or providers miscalculating doses of compounded injectable semaglutide.[1]
Improper Storage FDA has received complaints that compounded GLP-1 drugs arrived warm or with inadequate ice packs, potentially degrading the drug's quality and effectiveness.
Fraudulent Products The FDA has identified products labeled as "compounded" that were actually counterfeit, bearing fake pharmacy names and addresses that don't exist.
Illegal "Research" Products Some companies sell semaglutide falsely labeled "for research purposes" or "not for human consumption" directly to consumers with dosing instructions. These are illegal.[1]

Red Flags: How to Spot an Illegitimate Pharmacy or Product

Protect yourself by learning to recognize the warning signs of an unsafe seller or product. If you encounter any of these red flags, do not purchase or use the product.

Warning Signs of Illegitimate Semaglutide Products and Sellers
Red Flag Why It's a Problem
No Prescription Required Illegal. Selling a prescription drug without a prescription is against federal law. Any seller offering semaglutide without one is operating illegally.
Labeled "For Research Only" Not for Human Use. These products are not manufactured in FDA-regulated facilities and may be impure, contaminated, or incorrectly dosed.
Sold as Salts (Sodium/Acetate) Wrong Ingredient. This is not the same active ingredient as in Ozempic or Wegovy. The FDA has warned that these salts have unknown safety profiles.
Unusually Low Prices Too Good to Be True. Legitimate semaglutide costs $900+ per month at list price. Extreme discounts often indicate a counterfeit or substandard product.
Ships from a Foreign Country Unregulated. The product is not part of the secure, FDA-regulated U.S. drug supply chain and may have been stored improperly during transit.
Poor Packaging / Spelling Errors Counterfeit Indicator. Indicates a lack of quality control and is a hallmark of fraudulent pharmaceutical operations.

Download: Pharmacy Safety Checklist

Use our free printable checklist to verify your pharmacy and medication before you fill your next prescription. Protect yourself from counterfeit and unapproved semaglutide products.

Download Free Checklist (PDF)

What to Do If You Can't Find Your Dose

Even with the shortage resolved, you might face a temporary local outage. Here is a step-by-step guide to handle the situation safely without resorting to unverified sources.

  1. Don't Panic: A delay of a few days is unlikely to significantly impact your treatment. Do not seek out unverified online sources or compounding pharmacies.
  2. Ask Your Pharmacy to Check Other Locations: Large chains like CVS and Walgreens can check the inventory of all their stores in the area and may be able to transfer your prescription to a location with stock.
  3. Request a 90-Day Supply: Once you find a pharmacy with stock, ask your doctor to send a 90-day prescription. This reduces the frequency of refills and provides a buffer against any future localized disruptions.
  4. Contact Your Prescriber: If the delay is expected to be longer than 1–2 weeks, contact your healthcare provider. They may suggest a temporary switch to a different dose strength that is available, or they may recommend an alternative GLP-1 medication.
  5. Use Manufacturer Resources: Contact Novo Nordisk directly at 1-888-693-5262 for the latest product supply information and assistance locating a pharmacy with available stock.

Frequently Asked Questions

Is the Ozempic shortage really over?

Yes. According to the FDA's official Drug Shortages list, the shortages for both Ozempic and Wegovy were declared resolved as of February 2025. All dose strengths are now available at pharmacies nationwide. If your specific pharmacy is temporarily out of stock, this is a local issue, not a national shortage.[4]

Why is my specific pharmacy still out of stock?

This is likely a temporary, local issue related to that pharmacy's specific distributor or a regional spike in demand. It does not reflect a national shortage. Try calling other pharmacies in your area, or ask your pharmacist to check inventory at nearby locations within the same chain.

Is it safe to buy compounded semaglutide now?

No. The FDA strongly advises against it. The legal allowance for compounding was tied to the official shortage status. Now that the shortage is over, compounded versions are considered unapproved drugs with significant safety risks. As of July 2025, the FDA has received 605 adverse event reports for compounded semaglutide.[1]

What are semaglutide salts (sodium/acetate)?

These are different chemical forms of the semaglutide molecule that are not the same as the active ingredient in FDA-approved Ozempic and Wegovy. Their safety, bioavailability, and pharmacological properties in the human body are unknown. The FDA has warned against their use in compounding and states it is "not aware of any lawful basis" for their use.[1]

How can I tell if my Ozempic or Wegovy pen is counterfeit?

Check the packaging for spelling errors, compare the pen to photos on the official Ozempic or Wegovy websites, and ensure the label and box information match. The needle should be held in a paper tab, and the dose dial should not be easily extended. If the product arrived without proper refrigeration packaging, do not use it. When in doubt, contact Novo Nordisk at 1-888-693-5262 or ask your pharmacist to verify the product.

What should I do if I think I received a counterfeit drug?

Do not use it. Report it immediately to the FDA's MedWatch program online or by calling 1-888-INFO-FDA (1-888-463-6332). Also notify your pharmacist and prescribing doctor. Keep the product and its packaging as evidence for the investigation.

References

  1. FDA.gov. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Updated February 4, 2026.
  2. GoodRx Health. Are Compounded GLP-1s Going Away? Not Entirely. January 9, 2026.
  3. FDA.gov. FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs. February 7, 2026.
  4. FDA.gov. FDA Drug Shortages Database. Accessed February 8, 2026.
  5. NovoMedLink. Semaglutide Patient Safety Updates. January 15, 2026.